EUROGIN.COM
Welcome
Committee
Preliminary Prog
Overview
HPVI
STIs
S. Femmes
Symposia
Ed. material
Registration
Abstract submission
Proceeding
CME
Tech. info
Guideline
Grants
General Info
Partners
Sponsoring
Accomodation
Social programme
Contact
Sign up for our email mailing
list to receive updates
about Eurogin 2003.
Your email address:


SCIENTIFIC PROGRAMME

Sunday 13 April I Monday 14 April I Tuesday 15 April I Wednesday 16 April I

Monday 14 April 2003

Prevention and Control of Cervical Cancer in the New Millenium,
an International Commitment


PLENARY SESSIONS

These sessions are designed to present the most recent developments in cervical prevention, offering scientific excellence in the fields of screening, management and prevention, including emerging technologies, modern practice, and vaccine developments which are likely to improve or change clinical practice.
They are designed to bring together the main contributors to cervical cancer prevention, including experts and representatives of scientific societies, health organisations, women’s health institutions and decision-makers responding to the needs of patients, providers and public health authorities. An international charter aimed putting forward the priorities and directions to be taken to control the disease worldwide will be presented.

PS1 INTEGRATING EVIDENCE-BASED MEDICINE INTO CLINICAL PRACTICE

 

Chairs :T. Wright (USA), E. Franco (Canada)

• Cervical Cancer control, from past to present to future F. Montz (USA)
• Epidemiological evidence for the role of HPV in cervical cancer X. Bosch (Spain)
• Molecular evidence for HPV carcinogenesis A. Lorincz (USA)
• Cervical Cancer Screening, facing the reality in the world M. Parkin (France)
• New screening methods, challenging the success R. Richart (USA)
• Managing abnormal PAP, current practice protocols T. Cox (USA)

PS2 THE PATIENT: A WISE CONSUMER

 

Chairs : J. Austoker (UK), F. May Lewin (France)

• Women against cervical cancer L. Alexander (USA)

PS3 THE ROLE OF DECISION MAKERS AND INSTITUTIONS

 

Chairs : A. Miller (Germany), L. Abenhaim* (France)

• Impact of health economies E. Myers (France)
• The consensus conferences T. Wright (USA)
• Role of International Health Organisation and NGO A. Miller (Germany)

PS4 ACCREDITATION, CERTIFICATION, QUALITY SCIENCE EVALUATION PROGRAMS

 

Chairs : H.W. Lawson (USA), P. Walker (UK)

• The rationale H.W. Lawson (USA)
• Colposcopy: how it should be taught? A. Singer (UK)
• Colposcopy: who should perform it? H. Kitchener (UK)
• Cytopathology issues A.Verhest (Belgium), J. Linder (USA), A. Meisels (Canada)
• Evaluation programmes H W. Lawson (USA), J. Patnick (UK)

PS5 INNOVATION IN HIGH PERFORMANCE COMMUNICATION SYSTEMS

 

Chairs : L. Alexander (USA), G. Brugal* (France)
• Telecolposcopy D. G. Ferris (USA)
• Telecytopathology
• Health on the net C. Boyer (Switzerland)
• Communicating with the patients J. Austoker (UK)

 

PS6 MANAGEMENT PROTOCOLES OF CERVICAL NEOPLASIA

PS6-1 DIAGNOSIS OF CIN

 

Chairs : S. Dexeus (Spain), J. Jordan (UK)
• The Bethesda System 2001 T. Wright (USA)
• ASCUS T. Wright (USA)
• L. SIL E. Wilkinson (USA)
• H. SIL/ADC T. Cox (USA)
• Early Invasion E. Diakomanolis (Greece)

PS6-2 THE PRACTICALITY OF MANAGEMENT PROTOCOLS WORLDWIDE: AN INTERNATIONAL FORUM
  Chairs : S. Dexeus (Spain), J. Jordan (UK)
• International Federation of Colposcopy and Cervical Pathology (IFCCP) S. Dexeus (Spain)
• European Federation of Colposcopy (EFC) J. Jordan (UK)
• American Society of Colposcopy and Cervical Pathology (ASCCP) H. Jones (USA)

PS7 CONCLUSIONS: CERVICAL CANCER CONTROL, PRIORITIES AND NEW DIRECTIONS

 

Chairs :R. Richart (USA), P. Lopes (France)
• HPV C. Meijer (Netherlands) T. Cox (USA)
• Epidemiology X. Bosch (Spain) E. Franco (Canada)
• Cytopathology E. Mc Googan (UK) J. Linder (USA)
• Colposcopy/Management A. Singer (UK) J. Monsonego (France)
• Screening T. Wright (USA) R. Sankaranarayanan (F)
• Vaccines J. Schiller (USA) P. Coursaget (France),I. Frazer (Australia)



Congress Secretariat
VBCE – EUROGIN – C. Cabotin
33, rue de l’Abbé Groult, 75015 Paris - France
Tel. +33 (0)1 45 33 60 46
Fax +33 (0)1 45 33 57 15
admin@eurogin.com
Scientific Secretariat
EUROGIN
174, rue de Courcelles, 75017 Paris -France
Tel. +33 (0)1 44 40 01 20
Fax +33 (0)1 47 66 74 70
admin@eurogin.com